Citius Oncology, Inc. (CTOR)
0.7003
+0.03
(+4.37%)
USD |
NASDAQ |
Oct 21, 16:00
Citius Oncology Price to Book Value : 1.834 for Oct. 21, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 1.834 |
| October 20, 2026 | 1.757 |
| October 19, 2026 | 1.860 |
| October 16, 2026 | 2.011 |
| October 15, 2026 | 1.954 |
| October 14, 2026 | 2.052 |
| October 13, 2026 | 2.074 |
| October 12, 2026 | 2.128 |
| October 09, 2026 | 2.199 |
| October 08, 2026 | 2.187 |
| October 07, 2026 | 2.229 |
| October 06, 2026 | 2.226 |
| October 05, 2026 | 2.288 |
| October 02, 2026 | 2.488 |
| October 01, 2026 | 2.566 |
| September 30, 2026 | 2.645 |
| September 29, 2026 | 2.750 |
| September 28, 2026 | 2.697 |
| September 25, 2026 | 2.750 |
| September 24, 2026 | 2.750 |
| September 23, 2026 | 2.645 |
| September 22, 2026 | 2.802 |
| September 21, 2026 | 2.737 |
| September 18, 2026 | 2.985 |
| September 17, 2026 | 2.671 |
| Date | Value |
|---|---|
| September 16, 2026 | 2.498 |
| September 15, 2026 | 2.242 |
| September 14, 2026 | 2.462 |
| September 11, 2026 | 2.403 |
| September 10, 2026 | 2.383 |
| September 09, 2026 | 2.462 |
| September 08, 2026 | 2.433 |
| September 04, 2026 | 2.252 |
| September 03, 2026 | 2.075 |
| September 02, 2026 | 2.037 |
| September 01, 2026 | 1.964 |
| August 31, 2026 | 1.999 |
| August 28, 2026 | 2.031 |
| August 27, 2026 | 2.070 |
| August 26, 2026 | 2.061 |
| August 25, 2026 | 2.122 |
| August 24, 2026 | 1.964 |
| August 21, 2026 | 1.948 |
| August 20, 2026 | 1.988 |
| August 19, 2026 | 1.971 |
| August 18, 2026 | 1.841 |
| August 17, 2026 | 1.938 |
| August 14, 2026 | 2.383 |
| August 13, 2026 | 2.165 |
| August 12, 2026 | 2.125 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Citius Pharmaceuticals, Inc. | 0.1587 |
| ACADIA Pharmaceuticals, Inc. | 2.689 |
| Alnylam Pharmaceuticals, Inc. | 22.46 |
| Anika Therapeutics, Inc. | 1.985 |
| Savara, Inc. | 6.720 |
Price to Book Value Related Metrics
| PS Ratio | 9.273 |
| PEG Ratio | -0.0207 |
| Price | 0.7003 |
| Earnings Yield | -67.64% |
| Market Cap | 74.06M |
| PEGY Ratio | -0.0207 |